Epidemiology Practice Questions

Q: Which of the following conditions typically exhibits a bimodal distribution?

Hodgkin's lymphoma. ### Explanation **Correct Option: B. Hodgkin's lymphoma** In epidemiology, a **bimodal distribution** occurs when a disease exhibits two distinct peaks of incidence across different age groups. Hodgkin’s Lymphoma (HL) is the classic textbook example of this phenomenon. * **First Peak:** Occurs in young adults, typically between the ages of **15 and 35 years**. * **Second Peak:** Occurs in older adults, usually **after the age of 50–55 years**. The underlying etiology is believed to differ between these peaks; the first is often associated with socio-economic factors and Epstein-Barr Virus (EBV) in certain subtypes, while the second is more related to age-associated immune senescence. **Analysis of Incorrect Options:** * **A. Thyroid Carcinoma:** Generally shows a progressive increase in incidence with age, though Papillary Thyroid Cancer is common in middle-aged females. It does not follow a classic bimodal pattern. * **C. Renal Carcinoma:** Primarily a disease of the elderly, with peak incidence occurring between **60 and 70 years**. * **D. Liver Carcinoma (HCC):** Incidence typically rises steadily with age, often peaking in the **6th decade**, strongly linked to chronic Hepatitis B/C or cirrhosis. **High-Yield Clinical Pearls for NEET-PG:** * **Other Bimodal Diseases:** Besides Hodgkin's, other conditions showing bimodal peaks include **Acute Lymphoblastic Leukemia (ALL)** (peaks at age 2–5 and again in the elderly) and **Atopic Dermatitis**. * **Reed-Sternberg Cells:** The pathological hallmark of Hodgkin's Lymphoma ("Owl-eye appearance"). * **Epidemiological Curves:** A bimodal curve suggests that the population consists of two different groups with different levels of risk or different causative mechanisms.

Q: Japanese encephalitis is caused by which genus of mosquito?

Culex. **Explanation:** **Japanese Encephalitis (JE)** is a viral zoonotic disease caused by the JE virus (a Flavivirus). The primary vector for this disease is the **Culex** mosquito, specifically the species **Culex tritaeniorhynchus**. These mosquitoes are "paddy-field breeders," and the transmission cycle involves pigs (amplifying hosts) and water birds (reservoirs). **Analysis of Options:** * **A. Culex (Correct):** *Culex tritaeniorhynchus* is the principal vector in India. They are persistent night-biters and prefer outdoor resting (exophilic). * **B. Aedes:** This genus is primarily responsible for transmitting **Dengue, Chikungunya, Zika, and Yellow Fever**. *Aedes aegypti* is a day-biter and breeds in artificial containers. * **C. Mansonia:** These mosquitoes are the primary vectors for **Brugian Filariasis** (*Brugia malayi*). They are unique because their larvae attach to the roots of aquatic plants (e.g., *Pistia*) for respiration. * **D. Anopheles:** This genus is the well-known vector for **Malaria**. In India, *Anopheles stephensi* (urban) and *Anopheles culicifacies* (rural) are the major species. **High-Yield NEET-PG Pearls:** * **Amplifying Host:** Pigs are the most important amplifying hosts for JE (they develop high viremia without getting sick). * **Incidental/Dead-end Hosts:** Humans and horses (viremia is too low to infect mosquitoes). * **Vaccination:** The **SA-14-14-2** (live attenuated) vaccine is used under the Universal Immunization Programme (UIP) in endemic districts of India. * **Control:** The most effective environmental measure is "Water Management" in rice fields (Intermittent Irrigation).

Q: What is the definition of prevalence?

Proportion. **Explanation:** Prevalence is defined as the total number of all individuals (both old and new cases) who have a specific disease or condition at a particular point in time (or over a specified period) divided by the total population at risk. **Why Proportion is Correct:** In epidemiology, a **proportion** is a type of ratio where the numerator is always included in the denominator (A / A+B). Since the individuals with the disease (numerator) are part of the total population being studied (denominator), prevalence is expressed as a proportion (usually as a percentage). It describes the "burden of disease" in a population. **Why Other Options are Incorrect:** * **Rate:** A rate measures the speed at which an event occurs and includes **time** in the denominator (e.g., Incidence Rate). Prevalence does not measure the speed of new cases; it is a static "snapshot." * **Ratio:** While all proportions are ratios, a "Ratio" specifically refers to the relation between two independent quantities where the numerator is *not* part of the denominator (e.g., Male:Female ratio). * **Mean:** This is a measure of central tendency (average) and does not describe the frequency of disease occurrence in a population. **High-Yield Clinical Pearls for NEET-PG:** * **Formula:** Prevalence = Incidence × Mean Duration of Disease ($P = I \times D$). * **Incidence** is a **Rate** (measures new cases only). * **Prevalence** is a **Proportion** (measures all existing cases). * Prevalence is increased by: Longer duration of illness, prolongation of life without a cure, and in-migration of cases. * Prevalence is decreased by: High fatality rate, shorter duration of disease, and improved cure rates.

Q: What is the predictive value of a positive test?

True positive / (True positive + False positive) x 100. **Explanation:** **Positive Predictive Value (PPV)** is a measure of a diagnostic test's precision. It answers the clinical question: *"If a patient tests positive, what is the probability that they actually have the disease?"* 1. **Why Option B is Correct:** The formula for PPV is the ratio of **True Positives (TP)** to the **Total Number of Positive Tests** (which includes both True Positives and False Positives). * **Formula:** $PPV = \frac{TP}{TP + FP} \times 100$ This correctly identifies the proportion of "test-positive" individuals who are truly diseased. 2. **Why Other Options are Incorrect:** * **Options C and D:** These represent the "False Discovery Rate" or the proportion of errors among positive results. They do not reflect the predictive accuracy for the presence of disease. * **Note on Sensitivity:** Do not confuse PPV with **Sensitivity**. Sensitivity is $\frac{TP}{TP + FN}$, which measures how well the test identifies diseased individuals from the *total diseased population*, whereas PPV measures accuracy among those the *test labeled as positive*. 3. **High-Yield Clinical Pearls for NEET-PG:** * **Prevalence Dependency:** Unlike Sensitivity and Specificity (which are inherent to the test), PPV is **directly proportional to the prevalence** of the disease in the population. If prevalence increases, PPV increases. * **Screening Utility:** In clinical practice, PPV is more useful than sensitivity for a clinician when interpreting a lab report for an individual patient. * **Negative Predictive Value (NPV):** The counterpart is $NPV = \frac{TN}{TN + FN} \times 100$, which measures the probability that a person with a negative test is truly disease-free.

Q: Which of the following best defines "incidence"?

None of the above. **Explanation:** The correct answer is **None of the above** because the options provided fail to include the essential mathematical component of a **Rate**. **1. Why "None of the above" is correct:** Incidence is defined as the number of **new cases** occurring in a defined population during a specific period of time **per 1,000 (or other multiplier) population at risk**. Option A describes the *numerator* of the incidence formula but omits the *denominator* (population at risk). Without the denominator, it is merely a "count," not a "rate." Incidence is a true rate as it includes the dimension of time. **2. Analysis of Incorrect Options:** * **Option A:** This is the **Incidence Number** (count), not the Incidence Rate. A rate must express the relationship between the new cases and the population at risk. * **Option B:** This is the definition of **Point Prevalence**. Prevalence measures the total burden of disease (new + old cases) at a specific moment, whereas incidence measures the "flow" or "attack" of the disease. * **Option C:** This refers to the **Susceptible Pool**, which is used to determine the denominator for calculating incidence, but it does not define incidence itself. **3. NEET-PG High-Yield Pearls:** * **Formula:** $\text{Incidence} = \frac{\text{Number of new cases of specific disease during a given time period}}{\text{Population at risk during that period}} \times 1000$ * **Key Distinction:** Incidence = **New** cases (Rate); Prevalence = **All** cases (Ratio). * **Relationship:** $\text{Prevalence (P)} = \text{Incidence (I)} \times \text{Mean Duration of disease (D)}$. * **Utility:** Incidence is the best indicator for measuring the **efficacy of preventive programs** and determining the **etiology/risk** of acute diseases.

Q: Trachoma screening is performed on which of the following age groups?

1-9 years. **Explanation:** The correct answer is **1-9 years (Option C)**. This is based on the World Health Organization (WHO) guidelines for the elimination of Trachoma as a public health problem. **1. Why 1-9 years is correct:** Active Trachoma (characterized by follicular inflammation, or **TF**) is primarily a disease of childhood. The WHO uses the prevalence of **Trachoma Inflammation—Follicular (TF)** in children aged **1 to 9 years** as the key indicator to determine if a district requires mass drug administration (MDA) or if the disease has been eliminated. If the prevalence of TF in this age group is $\geq 5\%$, the SAFE strategy (Surgery, Antibiotics, Facial cleanliness, Environmental improvement) is implemented. **2. Why other options are incorrect:** * **Less than 5 years (Option A):** While children under 5 are highly susceptible, this range misses the older cohort (5-9 years) who still harbor significant infection and contribute to community transmission. * **5-10 years (Option B) & 5-15 years (Option D):** These ranges exclude toddlers (1-4 years), who often have the highest bacterial loads and are the primary reservoir for *Chlamydia trachomatis*. **3. High-Yield Clinical Pearls for NEET-PG:** * **SAFE Strategy:** **S**urgery (for Trichiasis), **A**ntibiotics (Azithromycin), **F**acial cleanliness, **E**nvironmental improvement. * **Drug of Choice:** A single dose of **Azithromycin (20 mg/kg)** is the mainstay of the 'A' in SAFE. * **Elimination Threshold:** Trachoma is considered eliminated as a public health problem when TF prevalence is **< 5%** in children aged 1–9 years and the Trachomatous Trichiasis (TT) rate is **< 0.2%** in adults over 15 years. * **India Status:** India was declared free from "Infective Trachoma" by the WHO in 2017, but surveillance continues in endemic pockets.

Question 1

What type of study is a cohort study?

Accepted Answer

Analytic observational

Answer

Descriptive observational

Answer

Experimental

Answer

Controlled trial

Question 2

Physicians likely have a higher index of suspicion for tuberculosis in children without a BCG scar compared to those with a BCG scar. If an association is found between tuberculosis and not having a BCG scar, what type of bias could explain this association?

Accepted Answer

Interviewer bias

Answer

Selection bias

Answer

Surveillance bias

Answer

Non-response bias

Question 3

Which of the following conditions typically exhibits a bimodal distribution?

Accepted Answer

Hodgkin's lymphoma

Answer

Thyroid carcinoma

Answer

Renal carcinoma

Answer

Liver carcinoma

Question 4

Japanese encephalitis is caused by which genus of mosquito?

Accepted Answer

Culex

Answer

Aedes

Answer

Mansonia

Answer

Anopheles

Question 5

What is the definition of prevalence?

Accepted Answer

Proportion

Answer

Rate

Answer

Ratio

Answer

Mean

Question 6

What is the predictive value of a positive test?

Accepted Answer

True positive / (True positive + False positive) x 100

Answer

False positive / (True positive + False positive) x 100

Answer

False positive / (True positive + False positive) x 100

Question 7

Which of the following best defines "incidence"?

Accepted Answer

None of the above

Answer

The number of new cases of a disease occurring in a defined population during a specified period.

Answer

The total number of existing cases (new and old) of a disease in a defined population at a particular point in time.

Answer

The proportion of individuals in a population who are susceptible to a disease.

Question 8

Which of the following best defines a carrier in the context of infectious diseases?

Accepted Answer

An infected person harboring an infectious agent without clinical features, acting as a source of infection.

Answer

A person, animal, or object from which an infectious agent passes to a susceptible host.

Answer

A person, animal, or object in which an infectious agent lives and multiplies.

Answer

A person in whom an infectious agent lies dormant.

Question 9

Trachoma screening is performed on which of the following age groups?

Accepted Answer

1-9 years

Answer

Less than 5 years

Answer

5-10 years

Answer

5-15 years

Question 10

A test has a sensitivity of 90% and a specificity of 95%. Which of the following statements is true?

Accepted Answer

Sensitivity equals the true positive rate (true positive / (true positive + false negative)).

Answer

The test is likely to be useful for general screening.

Answer

Sensitivity indicates that the test is negative when the disease is present.

Answer

10% of positive tests are false positives.

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?